Health News Roundup: AstraZeneca says U.S. to buy additional 500,000 Evusheld doses; Australia COVID-19 infections hit record amid runaway Omicron outbreak and more

The company said the delivery of the doses was expected in the first quarter of 2022 and more details about the deal would be announced in the coming weeks. Australia COVID-19 infections hit record amid runaway Omicron outbreak Australia on Thursday reported its biggest pandemic caseload with a runaway Omicron outbreak driving up hospitalisation rates as the surge put severe strain on supply chains forcing authorities to ease quarantine rules for more workers.


Reuters | Updated: 13-01-2022 10:34 IST | Created: 13-01-2022 10:30 IST
Health News Roundup: AstraZeneca says U.S. to buy additional 500,000 Evusheld doses; Australia COVID-19 infections hit record amid runaway Omicron outbreak and more
Representative image Image Credit: Pixabay

Following is a summary of current health news briefs.

AstraZeneca says U.S. to buy additional 500,000 Evusheld doses

AstraZeneca said on Wednesday the U.S. government has agreed to purchase an additional 500,000 doses of its antibody cocktail, Evusheld, used to treat COVID-19. The company said the delivery of the doses was expected in the first quarter of 2022 and more details about the deal would be announced in the coming weeks.

Australia COVID-19 infections hit record amid runaway Omicron outbreak

Australia on Thursday reported its biggest pandemic caseload with a runaway Omicron outbreak driving up hospitalisation rates as the surge put severe strain on supply chains forcing authorities to ease quarantine rules for more workers. After successfully containing the virus earlier in the pandemic, Australia has reported nearly a million cases over the last two weeks as people slowly get adjusted to living with the coronavirus amid fewer restrictions. Total infections detected since the pandemic began neared 1.4 million.

Explainer-Why you should still try to avoid catching Omicron

A fast-spreading Omicron variant that causes milder illness compared with previous versions of the coronavirus has fueled the view that COVID-19 poses less of a risk than in the past. In which case, some ask, why go to great lengths to prevent getting infected now, since everybody will be exposed to the virus sooner or later?

Another Chinese city detects Omicron case as Tianjin outbreak expands

The Chinese port city of Tianjin reported an increase in COVID-19 infections on Thursday as it stepped up efforts to rein in an outbreak that has spread the highly transmissible Omicron variant to another Chinese city. Omicron has brought fresh challenges to China's strategy to quickly extinguish local outbreaks, an approach that has taken on extra urgency in the run-up to the Winter Olympics starting on Feb. 4, as well as the Lunar New Year holiday peak travel season beginning later this month.

Pfizer study shows COVID-19 booster can be given along with pneumonia shot

Pfizer Inc said on Wednesday booster doses of its COVID-19 vaccine can be administered along with its pneumonia vaccine and produced strong safety and immune responses in people aged 65 and above in a late-stage study. The study, initiated in May, tested the company's next-generation pneumococcal conjugate vaccine, PREVNAR 20, with a third dose of the Pfizer-BioNTech COVID-19 shot in 570 participants.

Moderna expects COVID-19 vaccine trial data for children aged 2-5 in March

Moderna Inc said on Wednesday it expects to report data from its COVID-19 vaccine trial in children aged between 2 to 5 years in March. "If the data is supportive and subject to regulatory consultation, Moderna may proceed with regulatory filings for children 2-5 years of age thereafter," the company said.

Long COVID brain fog found similar to 'chemo brain'; clip-on device shows promise in virus detection

The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that has yet to be certified by peer review. Long COVID "brain fog" shares features with "chemo brain"

Omicron less severe than Delta but still poses danger for unvaccinated: WHO

The highly infectious Omicron coronavirus variant causes less severe disease than the Delta strain but it remains a "dangerous virus", particularly for those who are unvaccinated, the head of the World Health Organization (WHO) said on Wednesday. Speaking at a news briefing, director general Tedros Adhanom Ghebreyesus said more than 90 countries were yet to meet the target of vaccinating 40% of their populations and more than 85% of people in Africa were yet to receive a single dose.

Americans grapple with prolonged testing woes amid Omicron surge

Long lines snake around entire city blocks as Americans scramble to get tested for COVID-19. At-home testing kits fly off the shelves at pharmacies and drug stores. Demand that surged before the holidays has yet to subside in the new year. As the Omicron variant pushed infections to record levels and the Biden administration unveiled plans to double testing capacity in schools, people across the country voiced frustration on Wednesday with the paucity of tests.

Canada drops vaccine mandate for its truckers after pressure from industry

Canada will allow unvaccinated Canadian truckers to cross in from the United States, reversing a decision requiring all truckers to be inoculated against the coronavirus, Canada's border agency said on Wednesday. Canadian Prime Minister Justin Trudeau had faced pressure from the main opposition party and trucking lobby to drop the vaccine mandate for truckers, due to come into force on Saturday, saying it could result in driver shortages, disrupt trade and drive up inflation.

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)

Give Feedback